Covestor Ltd Purchases 259 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Covestor Ltd grew its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 57.7% during the 1st quarter, Holdings Channel.com reports. The firm owned 708 shares of the medical instruments supplier’s stock after acquiring an additional 259 shares during the period. Covestor Ltd’s holdings in ICU Medical were worth $76,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of ICUI. SG Americas Securities LLC purchased a new stake in ICU Medical during the 4th quarter valued at about $106,000. State of Alaska Department of Revenue boosted its holdings in ICU Medical by 417.8% during the 4th quarter. State of Alaska Department of Revenue now owns 12,475 shares of the medical instruments supplier’s stock valued at $1,244,000 after acquiring an additional 10,066 shares during the period. Private Trust Co. NA boosted its holdings in ICU Medical by 273.8% during the 4th quarter. Private Trust Co. NA now owns 1,200 shares of the medical instruments supplier’s stock valued at $120,000 after acquiring an additional 879 shares during the period. New York State Teachers Retirement System lifted its holdings in ICU Medical by 6.8% in the 4th quarter. New York State Teachers Retirement System now owns 27,566 shares of the medical instruments supplier’s stock worth $2,749,000 after buying an additional 1,761 shares during the period. Finally, Equitable Trust Co. lifted its holdings in ICU Medical by 30.6% in the 4th quarter. Equitable Trust Co. now owns 4,142 shares of the medical instruments supplier’s stock worth $413,000 after buying an additional 970 shares during the period. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Needham & Company LLC assumed coverage on ICU Medical in a report on Friday, June 21st. They issued a “hold” rating for the company. Raymond James upgraded ICU Medical from a “market perform” rating to an “outperform” rating and set a $135.00 price objective for the company in a report on Monday, June 17th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $127.00.

Insider Activity at ICU Medical

In related news, insider Ben Sousa sold 2,000 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $105.55, for a total transaction of $211,100.00. Following the completion of the transaction, the insider now owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other ICU Medical news, Director Elisha W. Finney sold 300 shares of ICU Medical stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the sale, the director now owns 2,129 shares of the company’s stock, valued at approximately $223,438.55. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Ben Sousa sold 2,000 shares of the firm’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of $105.55, for a total value of $211,100.00. Following the completion of the transaction, the insider now owns 1,319 shares in the company, valued at $139,220.45. The disclosure for this sale can be found here. Insiders sold a total of 14,839 shares of company stock valued at $1,546,014 in the last 90 days. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Trading Down 0.3 %

ICUI opened at $125.86 on Thursday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.09 and a current ratio of 2.61. The business has a 50 day moving average of $115.06 and a 200-day moving average of $105.22. ICU Medical, Inc. has a 52 week low of $78.28 and a 52 week high of $180.75.

ICU Medical (NASDAQ:ICUI) last released its earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating analysts’ consensus estimates of $0.54 by $0.06. The company had revenue of $566.66 million during the quarter, compared to analysts’ expectations of $553.15 million. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. As a group, research analysts predict that ICU Medical, Inc. will post 3.5 earnings per share for the current fiscal year.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.